ATyr Pharma Price Prediction
At the present time the value of rsi of ATyr Pharma's share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of ATyr Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of ATyr Pharma and does not consider all of the tangible or intangible factors available from ATyr Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with ATyr Pharma, which may create opportunities for some arbitrage if properly timed.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
Oversold Vs Overbought
0
Oversold | Overbought |
Using ATyr Pharma hype-based prediction, you can estimate the value of ATyr Pharma from the perspective of ATyr Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ATyr Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying ATyr because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ATyr Pharma after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ATyr |
ATyr Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ATyr Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ATyr Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ATyr Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 1 Events / Month | 8 Events / Month | Very soon |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.00 | 0.00 | 0.00 |
|
ATyr Pharma Hype Timeline
ATyr Pharma is now traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. ATyr is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on ATyr Pharma is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 62.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.3. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. ATyr Pharma recorded a loss per share of 0.88. The entity last dividend was issued on the 1st of July 2019. The firm had 1:14 split on the 1st of July 2019. Given the investment horizon of 90 days the next forecasted press release will be very soon. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.ATyr Pharma Related Hype Analysis
Having access to credible news sources related to ATyr Pharma's direct competition is more important than ever and may enhance your ability to predict ATyr Pharma's future price movements. Getting to know how ATyr Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ATyr Pharma may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
MREO | Mereo BioPharma Group | 0.02 | 8 per month | 0.00 | (0.14) | 4.80 | (6.31) | 17.36 | |
TERN | Terns Pharmaceuticals | 0.03 | 11 per month | 0.00 | (0.07) | 6.02 | (5.96) | 34.09 | |
PDSB | PDS Biotechnology Corp | 0.10 | 10 per month | 0.00 | (0.12) | 7.67 | (6.76) | 31.83 | |
INZY | Inozyme Pharma | (0.32) | 6 per month | 0.00 | (0.31) | 5.07 | (7.92) | 16.62 | |
HOOK | Hookipa Pharma | (0.19) | 7 per month | 0.00 | (0.33) | 6.85 | (7.24) | 22.98 | |
XFOR | X4 Pharmaceuticals | 0.00 | 10 per month | 0.00 | (0.04) | 8.82 | (10.61) | 62.35 | |
DAWN | Day One Biopharmaceuticals | (0.07) | 9 per month | 0.00 | (0.05) | 3.84 | (3.69) | 11.44 | |
ABOS | Acumen Pharmaceuticals | (0.04) | 8 per month | 0.00 | (0.09) | 7.52 | (6.78) | 28.07 | |
AMLX | Amylyx Pharmaceuticals | 0.14 | 9 per month | 4.07 | 0.27 | 10.06 | (6.13) | 33.56 |
ATyr Pharma Additional Predictive Modules
Most predictive techniques to examine ATyr price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ATyr using various technical indicators. When you analyze ATyr charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About ATyr Pharma Predictive Indicators
The successful prediction of ATyr Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ATyr Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ATyr Pharma based on analysis of ATyr Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ATyr Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ATyr Pharma's related companies.
Story Coverage note for ATyr Pharma
The number of cover stories for ATyr Pharma depends on current market conditions and ATyr Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ATyr Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ATyr Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ATyr Pharma Short Properties
ATyr Pharma's future price predictability will typically decrease when ATyr Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ATyr Pharma often depends not only on the future outlook of the potential ATyr Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ATyr Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 53.6 M | |
Cash And Short Term Investments | 98.2 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in ATyr Stock
If you are still planning to invest in ATyr Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ATyr Pharma's history and understand the potential risks before investing.
Transaction History View history of all your transactions and understand their impact on performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |